Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY 4.0Journal of Enzyme Inhibition and Medicinal Chemistry

Identification, optimisation, and structural elucidation of chloroacetamide scaffold as covalent inhibitors for ubiquitin C-terminal Hydrolase L3

2 more authors
7 affiliations
  1. 1Borch Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, Indiana, USA
  2. 2James Tarpo Jr. and Margaret Tarpo Department of Chemistry, College of Science, Purdue University, West Lafayette, Indiana, USA
  3. 3Department of Basic Medical Sciences, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA
  4. 4Purdue Institute for Cancer Research, Purdue University, West Lafayette, Indiana, USA
  5. 5Department of Biological Sciences, College of Science, Purdue University, West Lafayette, Indiana, USA
  6. 6Purdue University Interdisciplinary Life Sciences Program, Purdue University, West Lafayette, Indiana, USA
  7. 7Purdue Institute for Drug Discovery, Purdue University, West Lafayette, Indiana, USA

Abstract

The deubiquitinating enzyme, ubiquitin C-terminal hydrolase L3 (UCHL3), has been implicated as a potential therapeutic target for cancer with a role in regulating the DNA damage response pathways. While the target has been studied using genetic methods there is a lack of reliable chemical probes to selectivity target UCHL3. In this study we report hit identification and optimisation of a new chemical scaffold that irreversibly inhibits UCHL3. The observed structure-activity relationships are corroborated by ligand-bound crystal structures that confirm covalent adduct formation with the catalytic cysteine of the enzyme. Finally, through gel-shift assays using a ubiquitin activity-based probe we demonstrate on-target engagement with UCHL3 in two cell lines. The work as a whole presents a comprehensive evaluation of the new scaffold that can be utilised to probe UCHL3 in different biological contexts.

Related

  1. Preparation, Structural Elucidation, and In Silico Prebiotic Evaluation of Pectin Oligosaccharides from Apple Pectin
    Guoxiang Chi, Shuyu Zu, Yousi Fu +1
    BiomoleculesPeer-reviewedCC BY 4.0Full textGeneral biochemistryCrossrefEurope PMC
  2. Integrated hierarchical fusion of GRU and meta-features for enhanced identification and interpretation of calcium ion inhibitors
    Mir Tanveerul Hassan, Saima Gaffar, Waqar Ahmad +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  3. Recombinant SIRT1 expression and SIRT1 METTL3 interaction analysis with computational identification of phytochemical SIRT1 activators and inhibitors
    M. K. E. Hasan, M. N. H. Joy, L. Lin +11
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  4. ML-QSAR and Fragment Selectivity for the Identification of Fourth-Generation EGFRL858R/T790M/C797S Inhibitors
    Guo-Gang Tu
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  5. Identification of small-molecule inhibitors of the immune system repressor Regnase-1.
    Arthur Millius, Chee-Hong Takahiro Yew, Yuko Misumi +13
    NAR molecular medicinePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
BibTeX
@article{beeralingappa2026identification,
  title = {{Identification, optimisation, and structural elucidation of chloroacetamide scaffold as covalent inhibitors for ubiquitin C-terminal Hydrolase L3}},
  author = {Nagabhushana C. Beeralingappa and Mengyao Lu and Rishi Patel and Nipuni Pannala and Alisha Dhiman and Brittany N. Heil and Ryan D. Imhoff and Emily G. Smith and Mei B. Bahler and Haley L. Marsden and Brittany L. Allen-Petersen and Michael K. Wendt and Chittaranjan Das and Daniel P. Flaherty},
  journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
  year = {2026},
  month = nov,
  doi = {10.1080/14756366.2026.2755714},
  url = {https://doi.org/10.1080/14756366.2026.2755714},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Identification, optimisation, and structural elucidation of chloroacetamide scaffold as covalent inhibitors for ubiquitin C-terminal Hydrolase L3
AU  - Nagabhushana C. Beeralingappa
AU  - Mengyao Lu
AU  - Rishi Patel
AU  - Nipuni Pannala
AU  - Alisha Dhiman
AU  - Brittany N. Heil
AU  - Ryan D. Imhoff
AU  - Emily G. Smith
AU  - Mei B. Bahler
AU  - Haley L. Marsden
AU  - Brittany L. Allen-Petersen
AU  - Michael K. Wendt
AU  - Chittaranjan Das
AU  - Daniel P. Flaherty
PY  - 2026
DA  - 2026/11/04
JO  - Journal of Enzyme Inhibition and Medicinal Chemistry
DO  - 10.1080/14756366.2026.2755714
UR  - https://doi.org/10.1080/14756366.2026.2755714
AB  - The deubiquitinating enzyme, ubiquitin C-terminal hydrolase L3 (UCHL3), has been implicated as a potential therapeutic target for cancer with a role in regulating the DNA damage response pathways. While the target has been studied using genetic methods there is a lack of reliable chemical probes to selectivity target UCHL3. In this study we report hit identification and optimisation of a new chemical scaffold that irreversibly inhibits UCHL3. The observed structure-activity relationships are corroborated by ligand-bound crystal structures that confirm covalent adduct formation with the catalytic cysteine of the enzyme. Finally, through gel-shift assays using a ubiquitin activity-based probe we demonstrate on-target engagement with UCHL3 in two cell lines. The work as a whole presents a comprehensive evaluation of the new scaffold that can be utilised to probe UCHL3 in different biological contexts.
SN  - 1475-6366
SN  - 1475-6374
ER  -